Canakinumab Subcutaneous and Insulin glargine
Determining the interaction of Canakinumab Subcutaneous and Insulin glargine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Insulin Glargine (U-100) Cartridge Systems and Pens
- Canakinumab Subcutaneous-Insulin Glargine (U-100) Vials
- Canakinumab Subcutaneous-Insulin Glargine (U-300) Pens
- Canakinumab Subcutaneous-Insulin glargine and lixisenatide
- Canakinumab Subcutaneous-Insulin glargine and lixisenatide Subcutaneous
- Canakinumab Subcutaneous-Insulin glargine, recombinant Subcutaneous
- Insulin glargine-Canasa
- Insulin glargine-Canasa Pac rectal
- Insulin glargine-Canasa rectal
- Insulin glargine-Cancidas
- Insulin glargine-Candesartan
- Insulin glargine-Candesartan and Hydrochlorothiazide